GE HealthCare Technologies (GEHC)

Common Shares
Sell: $67.81|Buy: $68.40|Change: 2.66 (-3.78%)

Open 

$70.32


Previous close 

$70.33


Trade high 

$70.92


Volume 

8,115,286


Year high 

$94.80


Year low 

$57.65


Dividend yield 

0.18%


Market capitalisation 

$30.98 bn


P/E ratio 

16.20


ISIN 

US36266G1076


Share price

Dividends

PreviousLatest
Record date14/01/202525/04/2025
Ex-dividend date14/01/202525/04/2025
Payment date14/02/202515/05/2025
Amount$0.035$0.035

Performance 01/05/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
GE HealthCare Technologies- 3.78
More...

Company profile

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.